Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-10-13 MOEBIUS HANS Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −7,881 7,882
2022-06-30 PERCEPTIVE ADVISORS LLC Director Purchase +1,101,362 $2.99 $3.3M 4,797,278
2022-06-29 PERCEPTIVE ADVISORS LLC Director Purchase +270,000 $2.99 $807K 3,695,916
2022-06-28 MOEBIUS HANS Chief Medical Officer Purchase +10,000 $2.88 $29K 52,955
2022-06-23 Worthington Mark General Counsel Sale −2,614 $2.69 $7K 19,097
2022-06-23 MILESON GLENNA Chief Financial Officer Sale −2,614 $2.69 $7K 109,167
2022-06-23 Litton Mark James Chief Executive Officer Sale −7,960 $2.69 $21K 128,555
2022-06-23 Lenington Rachel Chief Operating Officer Sale −4,193 $2.69 $11K 5,807
2022-06-23 CHURCH KEVIN Executive VP, Research Sale −2,614 $2.69 $7K 57,695
2022-06-22 Worthington Mark General Counsel Grant or award +10,000 21,711
2022-06-22 MOEBIUS HANS Chief Medical Officer Grant or award +10,000 42,955
2022-06-22 MILESON GLENNA Chief Financial Officer Grant or award +10,000 111,781
2022-06-22 Litton Mark James Chief Executive Officer Grant or award +20,000 136,515
2022-06-22 Lenington Rachel Chief Operating Officer Grant or award +10,000 10,000
2022-06-22 CHURCH KEVIN Executive VP, Research Grant or award +10,000 60,309
2022-06-08 CHURCH KEVIN Executive VP, Research Exercise or conversion +2,500 $1.35 $3K 50,309
2022-06-08 CHURCH KEVIN Executive VP, Research Exercise or conversion · Stock Option (Right to Buy) −2,500 10,110
2022-05-20 PICKERING GRANT Director Grant or award · Stock Option (Right to Buy) +3,467 3,467
2022-05-20 Romano Kelly A Director Grant or award · Stock Option (Right to Buy) +13,871 13,871
2022-05-20 Kosacz Barbara Director Grant or award · Stock Option (Right to Buy) +13,871 13,871

Page 13 of 18 · 349 trades